Registry of Resorbable Magnesium Scaffolds for Coronary Artery Disease
Official title: RMS (Resorbable Magnesium Scaffolds) Registry
Run by Biotronik AG · NCT04679740 · Data updated 2026-11-12
This study is testing how well resorbable magnesium scaffolds work and if they are safe for people with coronary artery disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1106 (estimated) |
| Sponsor | Biotronik AG Industry-sponsored |
| Locations | 13 sites (Cairns and 12 other locations) |
| Status | Recruiting |
| Started | November 18, 2020 |
| Main results expected | May 2030 |
| Study ends | May 2030 |
| Registry record updated | November 21, 2025 |
| Trial ID | NCT04679740 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry are patients diagnosed with coronary artery disease who are eligible for treatment with resorbable magnesium scaffolds according to the instructions for use.
✕Probably not a fit
Patients who do not meet the inclusion criteria or have contraindications as per the instructions for use may not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This registry aims to evaluate the clinical performance and short-term safety of resorbable magnesium scaffolds (RMS) in patients with coronary artery disease. It follows the guidelines set by the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery, collecting real-world data on the use of Magmaris scaffolds. The study includes patients who meet the instructions for use without additional exclusion criteria, allowing for a broad assessment of the device's effectiveness in a clinical setting.
Why it matters
Potential benefit: If successful, this registry could provide valuable insights into the safety and efficacy of resorbable magnesium scaffolds, potentially improving treatment options for patients with coronary artery disease.
How similar studies have gone: While this registry approach is not novel, similar studies have shown promising results in evaluating the safety and effectiveness of resorbable scaffolds in coronary interventions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * According to the IFU Exclusion Criteria: * According to the IFU
Where it's running
-
Heart Center Segeberger Kliniken
Bad Segeberg, Germany Recruiting -
Centro Cardiologico Monzino
Milan, Lombardy, Italy Recruiting -
1 Wojskowy Szpital Kliniczny z Poliklinika SPZOZ w Lublinie
Lublin, Poland Recruiting -
Lindenhofspital
Bern, Switzerland Recruiting -
Centre Hospitalier Universitaire Vaudois
Lausanne, Switzerland Recruiting -
Solothurner Spitäler AG
Olten, Switzerland Recruiting
Show 7 more locations
-
Cairns Hospital
Cairns, Australia Completed -
Krankenhaus Buchholz
Buchholz, Germany Completed -
Klinikum Westfalen, Knappschaft KH
Dortmund, Germany Completed -
Klinikum Herford
Herford, Germany Completed -
Herz-und Gefäßzentrum Oberallgäu-Kempten
Kempten, Germany Completed -
Daugavpils Regional Hospital
Daugavpils, Latvia Completed -
SUSCCH Banska Bystrica
Banská Bystrica, Slovakia Completed
Study contacts
- Principal investigator: Stefano Galli, MD — Centro Cardiologico Monzino
- Study coordinator: Marina Gattiglio, Dr.
- Email: marina.gattiglio@teleflex.com
- Phone: +41754295843
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
-
Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in CABG Patients
This study tests whether the amount a patient’s pulse pressure varies during surgery relates to how quickly lactate levels drop after CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.